Riverview Trust Company’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
Other funds holding AGL
CDR
DCP
RSCM
Riverview Trust Company's AGL Position: Q4 2022 in Review
Riverview Trust Company sold out of Agilon Health (AGL) in Q4 2022, closing a stake of 31 shares — an estimated $18K sold.
Riverview Trust Company first reported a position in AGL in Q2 2022 and held it in 2 quarters. The position peaked at $18K in Q3 2022. 166 funds tracked by Wall St. Rank hold AGL as of Q4 2022.
- Riverview Trust Company reported no remaining Agilon Health position as of Q4 2022 after selling out during the quarter.
- Riverview Trust Company sold 31 Agilon Health shares in Q4 2022, an estimated $18K.
- Riverview Trust Company first reported a position in Agilon Health in Q2 2022 and held it in 2 quarters.
- Riverview Trust Company's Agilon Health position peaked at $18K in Q3 2022.
- 166 funds tracked by Wall St. Rank held Agilon Health as of Q4 2022.
Based on Riverview Trust Company's 13F filing for Q4 2022, filed 26 Jan 2023.